- Opioids produce tolerance i.e. dose escalation is required to maintain the same degree of analgesia, increasing risk of side-effects
- At the cellular level, tolerance is mediated by the DOP receptor
- Animal models where DOP is inactivated (by antagonism or genetic knock-out) there is reduced tolerance to MOP receptor agonists
- Models of MOP-agonist/DOP-antagonist bivalent ligands demonstrate reduced tolerance profile, decreased physical dependence (vs. morphine) and improved anti-nociceptive properties
Opioid-Related Harm
Opioid-Related Harm
This topic was a Final FRCA CRQ in February 2024.
Questions on risk factors for persistent post-operative opioid use, management of fentanyl patches and opioid equivalence were poorly answered.
Resources
- An international multidisciplinary consensus statement on the prevention of opioid-related harm in adult surgical patients (Anaesthesia, 2020)
- Opioid stewardship (BJA Education, 2023)
- Surgery and opioids: evidence-based expert consensus guidelines on the perioperative use of opioids in the United Kingdom (BJA, 2021)
- Opioids are effective anti-nociceptive medicines which are integral to analgesic strategies for the management of acute post-operative pain
- However opioid related-harms, including persistent post-operative opioid use, have contributed to a near-global opioid crisis, which has significant socio-economic repercussions
- Opioid-related harms include:
- Persistent (post-operative) opioid use (PPOU)
- Opioid-related adverse drug events
- Minor side-effects e.g. pruritus
- Gastrointestinal side-effects
- Opioid-induced ventilatory impairment (OIVI)
- Opioid-induced hyperalgesia (OIH)
- Non-medical opioid use e.g. opioid use disorder/addiction
- Opioid diversion (i.e. sharing with others) and dependence
- Immunomodulatory and immunosuppressive effects
- Drug-driving
| Pharmacological | Service under-provision | Patient | Prescription | Industry-level | Societal | Healthcare |
| Addictive properties of drugs | Lack of resources to support chronic pain patients | Pre-operative opioid exposure (dose-dependent effect, up to 10x ↑ risk) | Poor opioid stewardship | Aggressive marketing inc. falsified claims | Lack of safe disposal routes | Use of unidemsnional pain scores |
| Long-acting formulations | Lack of recognition of chronic pain | Past/current substance dependence inc. tobacco, alcohol | Repeat prescriptions | Misbranding | Socio-economic deprivation | Incentivisation |
| Compound analgesics | Chronic pain | Poor knowledge of rates of dependence | Sponsoring drug trials | Opioid diversion | ||
| Psychological co-morbidities e.g. anxiety, catastrophising, depression | Lack of de-prescribing | Fabricated research data | ||||
| Use of long-acting formulations |
- Patients taking any opioids prescribed post-operative pain for longer than 90 days after surgery
- The incidence of persistent post-operative opioid use ranges from 0.1 - 26% (opioid-naïve patients) to 35-77% (patients with previous opioid exposure)
- Although some surgeries are deemed 'higher risk' for PPOU, all patients undergoing surgery (even those considered 'low risk' surgeries) are at risk
- Described by some sources as the most common complication after surgery
- Coordinated interventions designed to improve, monitor and evaluate the use of opioids in order to support and protect health
- Effective stewardship is important in minimising risk of opioid-related harm
- Comprises of:
- Recognising risks of opioid-related harms
- Educating patients and healthcare providers
- Creating realistic patient expectations
- Use of multi-modal analgesia
- Controlled prescribing
- Early referral to pain specialists
Knowledge issues
- Insufficient understanding of the importance of opioid stewardship among healthcare professionals
- Opioid stewardship should be embedded in the curricula of healthcare professionals
- Staff need formal support and teaching for safe administration of opioids
- Insufficient understanding of opioid stewardship in patients and carers
- The peri-operative team should provide education to patients and carers regarding expectations of pain and opioid stewardship
- Clearly written patient information about the safe use of opioids should be available as leaflets or on websites
- Patients and carers should be advised about the dangers and the legal implications of driving while taking opioids for postoperative pain
Policies and guideline issues
- Lack of institutional guidance on prevention and management of PPOU and OIVI
- Multidisciplinary involvement of anaesthetists, surgeons, pain specialists, pharmacists, nursing staff, physiotherapists, primary care clinicians, hospital management, patients and carers is necessary to translate the recommendations from this consensus statement to local practice
- Hospitals should have strategies to mitigate the occurrence of OIVI and standardised order sets automatically linking prescribing, monitoring and interventions
- Pharmaceutical companies influencing guidelines; there should be clear separation between opioid manufacturers and the formulation of prescription practice guidelines
- Adherence to the ‘Pain is the 5th Vital Sign’ recommendations; opioid analgesia provision should be guided by functional outcomes, rather than unidimensional pain scores alone
- Inadequate safe disposal; patients and carers should be advised on safe storage and disposal of unused opioids, and directed to avoid opioid diversion (e.g. sharing with friends and family)
- Inadequate recognition and management of patients developing PPOU
- Refer surgical patients to pain specialists if still taking postoperative opioids beyond the normal healing period for that surgery and certainly if still taking opioids 90 days after surgery
Research and audit issues
- Lack of acknowledgement of regional and national differences in opioid prescribing
- Country-specific research is needed to address national and cultural issues around PPOU and OIVI
- Insufficient knowledge of optimal methods of implementing opioid stewardship
- Research should be undertaken into the optimal strategies required to implement safe opioid stewardship practices
- Insufficient appreciation of the prevalence of PPOU and incidence of OIVI
- Opioid-related serious adverse events should be routinely audited and investigated
Strategies to reduce risk of persistent post-operative opioid use
- Identify patients taking long-term opioids and wean or taper prior to surgery
- Identify psychological comorbidities and use psychological interventions to reduce anxiety, depression and catastrophic thinking
- Educate patients and carers about expected pain levels, pain management options including non-pharmacological methods, and safe use
- Use multi-modal opioid-sparing analgesic strategies to minimise opioid requirements
- Use functional outcomes rather than unidimensional pain scores to measure pain
- Identify early patients with abnormal pain trajectories as this may signify post-operative complications
- Use multi-modal analgesia including non-pharmacological techniques
- Avoid initiating long-acting or modified-release formulations
- Do not prescribe compound opioids
- Ongoing education about analgesia, safe use and non-pharmacological techniques
- Limit the volume and/or duration of opioids prescribed for discharge
- Quantity of dispensed opioids at discharge directly impacts opioid consumption after surgery
- 40-94% of opioid tablets prescribed end up being unused which poses risks
- Limit duration to 3-5 days, up to 7 days in some circumstances
- Educate patients and carers about reducing opioid use first (de-prescribing) when analgesic needs reduce
- Review the patient before dispersing more opioids; no automatic re-fills
- Each additional refill raises the risk of opioid misuse by 40%
- Each additional week of opioid use raises the risk of misuse by 20%
- Refer to a pain service if concerns re: chronic post-surgical pain
- Educate re: opioid storage and disposal to reduce opioid diversion and accidental overdose
- 90% fail to dispose of them
- 50% of adults and 55% of adolescents who misuse opioids obtain them via diversion
- Mortality from unintentional overdose has increase three-fold in the past 20yrs
- Advise patients of dangers and legal implications of driving while taking prescribed opioids